Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases

Tumor Necrosis ◽

Bowel Diseases ◽

Molecular Mechanism Of Action ◽

Inflammatory Bowel ◽

P154 PRIMARY NON-RESPONSE TO TUMOR NECROSIS FACTOR ANTAGONISTS IS ASSOCIATED WITH INFERIOR RESPONSE TO SECOND-LINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Gastroenterology ◽

10.1053/j.gastro.2017.11.204 ◽

2018 ◽

Vol 154 (1) ◽

pp. S81-S82

Author(s):

Siddharth Singh ◽

John George ◽

Brigid S. Boland ◽

Niels Vande Casteele ◽

William J. Sandborn

Keyword(s):

Systematic Review ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Second Line ◽

Tumor Necrosis Factor Antagonists ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy

Revista Española de Enfermedades Digestivas ◽

10.4321/s1130-01082010001000014 ◽

2010 ◽

Vol 102 (10) ◽

Cited By ~ 9

Author(s):

J. M. Ramos ◽

M. F. García-Sepulcre ◽

M. Masiá ◽

A. Brotons ◽

M. C. Grau ◽

...

Keyword(s):

Listeria Monocytogenes ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Listeria Monocytogenes Infection ◽

Bowel Diseases ◽

Factor Therapy ◽

Inflammatory Bowel ◽

S0861 Comparative Risk of Serious Infections With Tumor Necrosis Factor-α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000705492.87799.ce ◽

2020 ◽

Vol 115 (1) ◽

pp. S444-S445

Author(s):

Siddharth Singh ◽

Herbert Heien ◽

Jeph Herrin ◽

Parambir S. Dulai ◽

Lindsey Sangaralingham ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Serious Infections ◽

Bowel Diseases ◽

Comparative Risk ◽

Inflammatory Bowel ◽

Factor Α ◽

Neurological Adverse Effects Associated With Anti-tumor Necrosis Factor Alpha Antibodies in Pediatric Inflammatory Bowel Diseases

Journal of Pediatric Gastroenterology and Nutrition ◽

10.1097/mpg.0000000000002654 ◽

2020 ◽

Vol 70 (6) ◽

pp. 841-848

Author(s):

Valérie Bertrand ◽

Nathalie Massy ◽

Bénédicte Pigneur ◽

Stéphanie Coopman ◽

Geneviève Durrieu ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Adverse Effects ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Inflammatory Bowel Diseases

Digestive Diseases ◽

10.1159/000358151 ◽

2014 ◽

Vol 32 (4) ◽

pp. 446-454 ◽

Cited By ~ 4

Author(s):

Pierre Eftekhari ◽

Lisa Glaubitz ◽

Matthias Breidert ◽

Markus Friedrich Neurath ◽

Raja Atreya

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Prediction Of Response ◽

Bowel Diseases ◽

Factor Therapy ◽

Inflammatory Bowel ◽

P154 PRIMARY NON-RESPONSE TO TUMOR NECROSIS FACTOR ANTAGONISTS IS ASSOCIATED WITH INFERIOR RESPONSE TO SECOND-LINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS

10.1093/ibd/izy037.025 ◽

2018 ◽

Vol 24 (suppl_1) ◽

pp. S57-S57

Author(s):

Siddharth Singh ◽

John George ◽

Brigid S Boland ◽

Niels Vande Casteele ◽

William J Sandborn

Keyword(s):

Systematic Review ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Second Line ◽

Tumor Necrosis Factor Antagonists ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TUMOR NECROSIS FACTOR AGENTS IN OLDER ADULTS WITH INFLAMMATORY BOWEL DISEASES IN MEDICARE ADMINISTRATIVE CLAIMS DATABASE

Gastroenterology ◽

10.1053/j.gastro.2021.01.047 ◽

2021 ◽

Vol 160 (3) ◽

pp. S6-S7

Author(s):

Bharati Kochar ◽

Virginia Pate ◽

Michael Kappelman ◽

Millie Long ◽

Ashwin Ananthakrishnan ◽

...

Keyword(s):

Older Adults ◽

Tumor Necrosis Factor ◽

Comparative Effectiveness ◽

Tumor Necrosis ◽

Administrative Claims ◽

Claims Database ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Pustular Skin Reaction to Tumor Necrosis Factor Alpha Antagonists in Patients with Inflammatory Bowel Diseases

10.1097/mib.0000000000000600 ◽

2015 ◽

Vol 21 (11) ◽

pp. E26-E27 ◽

Cited By ~ 2

Author(s):

Angelo V. Marzano ◽

Simona Tavecchio ◽

Emilio Berti ◽

Carlo Gelmetti ◽

Massimo Cugno

Keyword(s):

Tumor Necrosis Factor ◽

Skin Reaction ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Healing of Apical Periodontitis in Patients with Inflammatory Bowel Diseases and under Anti–tumor Necrosis Factor Alpha Therapy

Journal of Endodontics ◽

10.1016/j.joen.2018.09.004 ◽

2018 ◽

Vol 44 (12) ◽

pp. 1777-1782 ◽

Cited By ~ 3

Author(s):

Elisabetta Cotti ◽

Silvia Mezzena ◽

Elia Schirru ◽

Olimpia Ottonello ◽

Michela Mura ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Alpha Therapy ◽

Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases

Gastroenterology ◽

10.1053/j.gastro.2019.07.025 ◽

2019 ◽

Vol 157 (5) ◽

pp. 1279-1292.e11 ◽

Cited By ~ 40

Author(s):

Konrad Aden ◽

Ateequr Rehman ◽

Silvio Waschina ◽

Wei-Hung Pan ◽

Alesia Walker ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Gut Microbes ◽

Metabolic Functions ◽

Tumor Necrosis Factor Antagonists ◽

Bowel Diseases ◽

Inflammatory Bowel ◽